An Efficacy and Safety Study of Telaprevir in Patients With Genotype 1 Hepatitis C Infection After Liver Transplantation
Clinical trial NCT01571583 · COMPLETED
Trial details
- NCT number
- NCT01571583
- Sponsor
- Janssen-Cilag International NV
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2012-02-01
- Primary completion
- 2014-04-01
- Enrollment
- 74
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.